Grupo de investigación en Diagnóstico Molecular de Tumores Ginecológicos

Presentación de la unidad de investigación

Our team has recently identified novel differential genetic targets that have the potential to discriminate gynecological tumors at the tissue level; however a major challenge remains in developing accurate and non-invasive diagnostic methods, mainly in areas such as gynecological oncology. In this sense, we are pursuing novel approaches to shift the diagnostic and therapeutic strategies toward a targeted and early preoperative assessment of malignancy risk. Through single-cell sequencing, we seek to capture tumor heterogeneity and change the clinical interventions from the total cell mass of the tumor to specific cellular subpopulations. Moreover, our research based on liquid biopsy also offers promising avenues for the development of predictive models that support differential diagnosis. This advancement could play a crucial role in detecting malignant gynecologic tumors earlier, also avoiding the risk of undetected metastatic spread.